Marex Group’s Aveanna Healthcare AVAH Stock Holding History

Marex Group’s Portfolio AVAH Stock Details AVAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-50,000	Closed	-$322K	–	1141
2026 Q1	$322K	Buy	+50,000	New	+$387K	﹤0.01%	754

Other funds holding AVAH

BCI

Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return

JHWEPV

J.H. Whitney Equity Partners VII New Canaan, Connecticut $232M AUM 63.86% 1-Year Est. Return

NTCM

Nut Tree Capital Management New York $419M AUM 65.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Marex Group's AVAH Position: Q2 2026 in Review

Marex Group sold out of Aveanna Healthcare (AVAH) in Q2 2026, closing a stake of 50,000 shares — an estimated $322K sold.

Marex Group first reported a position in AVAH in Q1 2026 and held it in 1 quarter. The position peaked at $322K in Q1 2026. 215 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

Marex Group reported no remaining Aveanna Healthcare position as of Q2 2026 after selling out during the quarter.
Marex Group sold 50,000 Aveanna Healthcare shares in Q2 2026, an estimated $322K.
Marex Group first reported a position in Aveanna Healthcare in Q1 2026 and held it in 1 quarter.
Marex Group's Aveanna Healthcare position peaked at $322K in Q1 2026.
215 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.